Follow The Filings

CSTL Castle Biosciences Inc.

Health Care, filed as Castle Biosciences Inc (COMMON STOCK), Equity Among managers we track Quote on Google Finance, opens in a new tab

No current holdings among managers we track for this security. See ownership history or the ownership grid, activity, or search.

Insider trades

Open-market buys and sales by CSTL's executives, directors and 10% owners in the last 12 months, from their Form 4s

All CSTL insider trades
  • None no insider bought on the open market
  • $3M sold by 4 insiders outside a trading plan
  • $16.7M sold by 4 insiders under 10b5-1 plans
  1. Derek J Maetzold Pres. & Chief Exec. Officer
    Planned sale
    $523K 14,496 shares at $36.10
    Traded Nov 2 Filed Nov 4
    ↗
  2. Tobin W Juvenal Chief Commercial Officer
    Planned sale
    $240K 6,578 shares at $36.42 15% of stake
    Traded Oct 28 Filed Oct 30
    ↗
  3. Tobin W Juvenal Chief Commercial Officer
    Planned sale
    $109K 3,288 shares at $33.08 6.7% of stake
    Traded Oct 26 Filed Oct 28
    ↗
  4. Derek J Maetzold Pres. & Chief Exec. Officer
    Planned sale
    $463K 14,496 shares at $31.91
    Traded Oct 19 Filed Oct 21
    ↗
  5. Tobin W Juvenal Chief Commercial Officer
    Planned sale
    $111K 3,288 shares at $33.64 6.3% of stake
    Traded Oct 12 Filed Oct 14
    ↗
  6. Derek J Maetzold Pres. & Chief Exec. Officer
    Planned sale
    $516K 14,496 shares at $35.57
    Traded Oct 5 Filed Oct 7
    ↗
  7. Kristen M Oelschlager COO
    Planned sale
    $149K 4,153 shares at $35.95 24% of stake
    Traded Oct 1 Filed Oct 5
    ↗
  8. Tobin W Juvenal Chief Commercial Officer
    Planned sale
    $232K 6,577 shares at $35.29 11% of stake
    Traded Sep 29–30 Filed Oct 1
    ↗
  9. Derek J Maetzold Pres. & Chief Exec. Officer
    Planned sale
    $512K 14,496 shares at $35.33
    Traded Sep 21 Filed Sep 23
    ↗
  10. Tobin W Juvenal Chief Commercial Officer
    Planned sale
    $223K 6,600 shares at $33.73 10% of stake
    Traded Sep 14–15 Filed Sep 16
    ↗
  11. Derek J Maetzold Pres. & Chief Exec. Officer
    Planned sale
    $465K 14,518 shares at $32.02
    Traded Sep 11 Filed Sep 15
    ↗
  12. Kristen M Oelschlager COO
    Planned sale
    $139K 4,152 shares at $33.39 24% of stake
    Traded Sep 1 Filed Sep 3
    ↗
  13. Tobin W Juvenal Chief Commercial Officer
    Planned sale
    $57K 1,730 shares at $32.81 2.6% of stake
    Traded Aug 31 Filed Sep 2
    ↗
  14. Derek J Maetzold Pres. & Chief Exec. Officer
    Planned sale
    $616K 18,560 shares at $33.20
    Traded Aug 28 Filed Sep 1
    ↗
  15. Tobin W Juvenal Chief Commercial Officer
    Planned sale
    $317K 9,050 shares at $35.04 12% of stake
    Traded Aug 25 Filed Aug 27
    ↗

Also filed in the last 12 months, not counted as buying or selling: 50 option exercises, 16 share withholdings for taxes, and 4 stock grants.

SEC filings

Recent issuer filings from EDGAR, 5 shown.

Filed Form Detail Links
10-Q Filing Doc
8-K 2.02,7.01,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 2.02,7.01,9.01 Filing Doc
10-Q Filing Doc

Source: SEC EDGAR submissions, updated about 13 hours ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Revenue $219.79M $332.07M $344.23M
Gross profit * $174.81M $271.86M $273.2M
Gross margin * 79.5% 81.9% 79.4%
Net income -$57.47M $18.24M -$24.16M
Net margin * -26.1% 5.5% -7.0%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $295.64M $360.15M $361.1M
Total non-current assets * $157.7M $171.08M $217.46M
Total assets $453.34M $531.24M $578.56M
Total current liabilities $47.67M $49.39M $68.68M
Total non-current liabilities * $14.4M $26.01M $39.01M
Total equity $391.27M $455.84M $470.87M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$5.63M $64.87M $64.35M
Cash from investing -$16.18M -$50.14M -$60.37M
Cash from financing -$2.3M $6.14M -$6.96M
Net change in cash -$24.11M $20.87M -$2.98M

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.

Further reading

As an Amazon Associate, FollowTheFilings earns from qualifying purchases.

More on the shelf